News
Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food ...
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug ...
3d
HealthDay on MSNFDA Warns of Heart Risk With Pfizer, Moderna COVID VaccinesKey Takeaways Federal regulators have issued a warning about rare heart inflammation in young males after mRNA COVID ...
3d
Pharmaceutical Technology on MSNModerna shares down after pulling Covid-flu combo vaccine applicationAfter the FDA asked for more clinical data in May 2025, Moderna has decided to resubmit the BLA later this year.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Biden officials hid health risks of COVID vaccines, report revealsThe FDA is forcing Pfizer and Moderna to use expanded ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...
FDA Flags Heart Risks in Moderna, Pfizer Shots Amid Renewed Concerns WASHINGTON, May 23 — COVID-19 Vaccine Warning from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results